News

Published on 3 May 2024 on Insider Monkey via Yahoo Finance

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript


Article preview image

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024

G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.19. GTHX isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day, and thank you for standing by. Welcome to the G1 Therapeutics First Quarter 2024 Financial Results. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Will Roberts. Please go ahead.

NASDAQ.GTHX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
It's Probably Less Likely That G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Will...

Key Insights G1 Therapeutics will host its Annual General Meeting on 13th of JuneTotal pay for CE...

Simply Wall St. ยท via Yahoo Finance 19 Jun 2024

G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed...

Shareholders of G1 Therapeutics, Inc. (NASDAQ:GTHX) will be pleased this week, given that the sto...

Simply Wall St. via Yahoo Finance 4 May 2024

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024 G1 Therapeutics,...

Insider Monkey via Yahoo Finance 3 May 2024

Earnings call: G1 Therapeutics reports growth and optimistic outlook By Investing.com

G1 Therapeutics (NASDAQ:GTHX) has reported promising financial results in their first-quarter...

Investing.com 2 May 2024

G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections

Revenue: Reported $14.1 million from COSELA sales in Q1 2024, slightly below the estimated $15.26...

GuruFocus.com via Yahoo Finance 1 May 2024

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit

We feel now is a pretty good time to analyse G1 Therapeutics, Inc.'s (NASDAQ:GTHX) business as it...

Simply Wall St. via Yahoo Finance 19 Apr 2024

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript February 28, 2024 G1 Therape...

Insider Monkey via Yahoo Finance 29 Feb 2024

G1 Therapeutics Inc (GTHX) Reports Strong Revenue Growth in 2023

Net Revenue Growth: G1 Therapeutics Inc (NASDAQ:GTHX) achieved a 48% increase in net revenue from...

GuruFocus.com via Yahoo Finance 28 Feb 2024

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60%...

Key Insights The considerable ownership by individual investors in G1 Therapeutics indicates that...

Simply Wall St. via Yahoo Finance 17 Feb 2024

Insider Sell: President and CEO Bailey John E. (Jack) Jr. Sells 32,983 Shares of G1 Therapeutics Inc

On January 2, 2024, Bailey John E. (Jack) Jr., the President and CEO of G1 Therapeutics Inc (NASD...

GuruFocus.com via Yahoo Finance 3 Jan 2024